Healthcare Analytical Testing Services Market Report 2025

This Healthcare Analytical Testing Services market report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.

The healthcare analytical testing services market size has grown rapidly in recent years. It will grow from $6.63 billion in 2024 to $7.62 billion in 2025 at a compound annual growth rate (CAGR) of 14.9%. The growth in the historic period can be attributed to regulatory compliance, drug development and approval, clinical trials expansion, rise aging population, increased chronic diseases.

The healthcare analytical testing services market size is expected to see rapid growth in the next few years. It will grow to $13.04 billion in 2029 at a compound annual growth rate (CAGR) of 14.4%. The growth in the forecast period can be attributed to telemedicine and remote monitoring, drug safety and pharmacovigilance, biopharmaceuticals and biosimilars, emerging markets, regulatory stringency. Major trends in the forecast period include advanced analytical techniques, data security and privacy, personalized medicine testing, ai and machine learning applications, environmental and contaminant testing.

The healthcare analytical testing services market is poised for growth, primarily driven by the increasing incidence of chronic diseases. Chronic diseases, lasting for more than three months, encompass conditions like arthritis, asthma, cancer, and diabetes. Healthcare analytical testing services play a crucial role in the diagnosis and early treatment of millions of patients suffering from chronic diseases. For example, diabetes cases in India are projected to double to 134 million by 2025, highlighting the growing prevalence of chronic diseases and the consequent demand for analytical testing services. The surge in chronic disease cases is a key factor propelling the expansion of the healthcare analytical testing services market.

The rising number of clinical trials is anticipated to drive the growth of the healthcare analytical testing services market. Clinical trials are research studies involving human participants to assess the safety and efficacy of medical treatments or interventions. Healthcare analytical testing services are utilized in these trials to evaluate drug safety and efficacy, dosing and formulation, data integrity, and quality control. For instance, in October 2023, ClinicalTrials.gov, a division of the National Institutes of Health (NIH), a US-based government agency responsible for conducting and supporting medical research, reported that the number of registered studies rose from 437,523 in 2022 to 468,457 across all 50 states in the United States and 221 countries worldwide. Additionally, it was noted that 143,613 studies (31% of the total) are registered in the U.S. alone, while 251,159 studies (54% of the total) are registered in non-U.S. locations. Therefore, the increasing number of clinical trials is expected to significantly propel the growth of the healthcare analytical testing services market.

Technological advancement is a prominent trend shaping the healthcare analytical testing services market. Major market players are actively investing in innovative technologies to maintain a competitive edge. In April 2022, Charles River Laboratories International Inc. and Valo Health Inc., both U.S.-based companies operating in drug discovery and analytical services, launched the Logica analytical platform. This platform, powered by artificial intelligence, is designed to assist in drug molecule design, synthesis capabilities, and DNA-encoded libraries. It translates biological testing outputs into optimized preclinical results, enhancing drug discovery and biological testing processes. Technological advancements such as the Logica analytical platform signify a commitment to innovation and are pivotal in sustaining market leadership in the healthcare analytical testing services segment.

Major companies in the healthcare analytical testing services market are concentrating on innovative offerings, such as analytical services tailored for drug developers and manufacturers, to secure a competitive edge. These analytical services involve laboratory testing and analysis to guarantee the quality, safety, and efficacy of pharmaceutical products throughout their development and manufacturing processes. For example, in December 2022, the United States Pharmacopeia (USP), a US-based scientific non-profit organization, introduced R&D Analytical Solutions services, which include drug assays, cleaning validation, purity analysis, and process analytical technology.

In September 2024, Pace Life Sciences, a US-based contract development and manufacturing organization (CDMO), acquired Catalent Small Molecule Analytical Services from Catalent for an undisclosed amount. This acquisition enables Pace to enhance its capabilities as a comprehensive analytical outsourcing provider, particularly in assisting clients during the early stages of drug research and development through to commercialization. Catalent is a US-based provider of analytical services for drug development.

Major companies operating in the healthcare analytical testing services market include Almac Group, ALS Limited, Anacura Life Sciences, Charles River Laboratories International Inc., Danaher Corporation, Element Materials Technology Group, Eurofins Scientific SE, ICON plc, Impact Analytical Testing Lab, Intertek Group plc, Merck KGaA, Pace Analytical Services LLC, PPD Inc., Sartorius AG, SourceBio International plc, Steris Corporation, Syneos Health Inc., Thermo Fisher Scientific Inc., WuXi AppTec, Analytical Bio-Chemistry (ABC) Laboratories, Avance Biosciences, Avista Pharma Solutions, Avomeen Analytical Services, BioPharma Services Inc., Boston Analytical, Exova, Laboratory Corporation, MedPharm Inc., Micro Quality Labs, Microbac Laboratories, Microbac Laboratories Inc., Nelson Laboratories LLC, Pacific Biolabs Inc., PPD Inc.

North America was the largest region in the healthcare analytical testing services market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the healthcare analytical testing services market share report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the healthcare analytical testing services market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

Healthcare analytical testing services involve the validation of procedures utilized in drug discovery and development, the assessment of finished products, and the detection of microorganisms in biological drugs, suspensions, and emulsions.

The primary types of healthcare analytical testing services encompass bioanalytical testing services, physical characterization services, method development and validation testing services, raw material testing services, batch-release testing services, stability testing, microbial testing services, and others. Bioanalytical testing services leverage medical devices to provide insights into pharmacokinetics and pharmacodynamics, determining drug and metabolite content in blood and urine for pharmacological and toxicological research. The term 'bioanalytical' specifically refers to the process of detecting metabolites in biological fluids. Various end users of healthcare analytical testing services include pharmaceutical and biopharmaceutical companies, medical device companies, and clinical research organizations. These services play a critical role in ensuring the quality and safety of healthcare products and contribute to advancements in pharmacological and toxicological research.

The healthcare analytical testing services market research report is one of a series of new reports that provides healthcare analytical testing services market statistics, including healthcare analytical testing service industry global market size, regional shares, competitors with a healthcare analytical testing services market share, detailed healthcare analytical testing services market segments, market trends and opportunities, and any further data you may need to thrive in the healthcare analytical testing service industry. This healthcare analytical testing services market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

The healthcare analytical testing services market includes revenues earned by providing services such as environmental monitoring services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.